DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Sandborn WJ, Feagan BG, Rutgeerts P et al.
Vedolizumab as induction and maintenance therapy for Crohn’s disease.
N Engl J Med 2013;
369: 711-721
We do not assume any responsibility for the contents of the web pages of other providers.